ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Nevada » Ophthalmology

Top Ophthalmology Prescribers in Nevada

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
PETER DEBRY M.D

Ophthalmology

7,295

$430K

1191
1094 are 65+

1%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

61%
prescriptions for brand name drugs

Avg: 55%

$59
Average prescription price

Avg: $62

KEVIN MILLER M.D.

Ophthalmology

7,105

$375K

973
924 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

47%
prescriptions for brand name drugs

Avg: 55%

$53
Average prescription price

Avg: $62

DAN EISENBERG M.D.

Ophthalmology

5,023

$141K

719
685 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

33%
prescriptions for brand name drugs

Avg: 55%

$28
Average prescription price

Avg: $62

MICHAEL STANKO MD

Ophthalmology

4,522

$375K

787
719 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

61%
prescriptions for brand name drugs

Avg: 55%

$83
Average prescription price

Avg: $62

EVA LIANG MD

Ophthalmology

4,086

$152K

885
851 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

28%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

62%
prescriptions for brand name drugs

Avg: 55%

$37
Average prescription price

Avg: $62

RENE ZAMORA MD

Ophthalmology

3,830

$453K

1025
955 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

85%
prescriptions for brand name drugs

Avg: 55%

$118
Average prescription price

Avg: $62

ROBERT WOLFF M.D.

Ophthalmology

3,219

$244K

717
647 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

70%
prescriptions for brand name drugs

Avg: 55%

$76
Average prescription price

Avg: $62

MATTHEW MILLS MD

Ophthalmology

3,076

$175K

601
552 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

55%
prescriptions for brand name drugs

Avg: 55%

$57
Average prescription price

Avg: $62

SURJEET SINGH M.D.

Ophthalmology

3,032

$225K

841
772 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

76%
prescriptions for brand name drugs

Avg: 55%

$74
Average prescription price

Avg: $62

STEVEN HANSEN M.D.

Ophthalmology

2,960

$136K

738
694 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

66%
prescriptions for brand name drugs

Avg: 55%

$46
Average prescription price

Avg: $62

TUSHINA REDDY M.D.

Ophthalmology

2,547

$146K

654
608 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

53%
prescriptions for brand name drugs

Avg: 55%

$58
Average prescription price

Avg: $62

EMILY FANT M.D.

Ophthalmology

2,496

$114K

528
487 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

54%
prescriptions for brand name drugs

Avg: 55%

$46
Average prescription price

Avg: $62

GREGORY COHEN MD

Ophthalmology

2,479

$160K

466
431 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

54%
prescriptions for brand name drugs

Avg: 55%

$65
Average prescription price

Avg: $62

HELGA PIZIO M.D.

Ophthalmology

2,435

$162K

647
583 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

80%
prescriptions for brand name drugs

Avg: 55%

$66
Average prescription price

Avg: $62

CURTIS MANNING M.D.

Ophthalmology

2,431

$178K

516
470 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

56%
prescriptions for brand name drugs

Avg: 55%

$73
Average prescription price

Avg: $62

WELDON HAVINS M.D.

Ophthalmology

2,424

$122K

477
449 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

47%
prescriptions for brand name drugs

Avg: 55%

$50
Average prescription price

Avg: $62

RAVINDRANATH REDDY M.D.

Ophthalmology

2,311

$95.8K

735
689 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

49%
prescriptions for brand name drugs

Avg: 55%

$41
Average prescription price

Avg: $62

STEVEN MONTGOMERY M.D.

Ophthalmology

2,297

$58.6K

575
520 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

40%
prescriptions for brand name drugs

Avg: 55%

$26
Average prescription price

Avg: $62

MEHDI VAZEEN M.D.

Ophthalmology

2,270

$90K

563
524 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

11%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

42%
prescriptions for brand name drugs

Avg: 55%

$40
Average prescription price

Avg: $62

ZIQIANG WU MD

Ophthalmology

2,248

$135K

544
503 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

55%
prescriptions for brand name drugs

Avg: 55%

$60
Average prescription price

Avg: $62

KENNETH HOUCHIN M. D.

Ophthalmology

2,239

$135K

371
315 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 3%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

53%
prescriptions for brand name drugs

Avg: 55%

$60
Average prescription price

Avg: $62

KENT WELLISH M.D.

Ophthalmology

2,124

$159K

575
504 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

65%
prescriptions for brand name drugs

Avg: 55%

$75
Average prescription price

Avg: $62

DOUGLAS LORENZ D.O.

Ophthalmology

1,968

$139K

563
520 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

14%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

58%
prescriptions for brand name drugs

Avg: 55%

$71
Average prescription price

Avg: $62

CHRISTOPHER SHEN MD

Ophthalmology

1,925

$132K

368
327 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

62%
prescriptions for brand name drugs

Avg: 55%

$69
Average prescription price

Avg: $62

ROBERT TAYLOR M.D.

Ophthalmology

1,881

$106K

553
521 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

60%
prescriptions for brand name drugs

Avg: 55%

$56
Average prescription price

Avg: $62

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank